Últimas noticias
Hemanext Inc. Announces a Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA) LEXINGTON, Mass., September 21, 2023, –Hemanext Inc., a leading innovator in blood processing, storage, and...
Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth
LEXINGTON, Mass., September 18, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, marks a significant turning point in its history as the company announces the retirement of its founder, Martin Cannon. Simultaneously,...
Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
LEXINGTON, Mass., July 5, 2023, – Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced its membership in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the region's premier trade association...
Hemanext anuncia una asociación con Aplastic Anemia & MDS International Foundation
LEXINGTON, Massachusetts, 2 de febrero de 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” o la “Empresa”), un innovador líder en tecnología de procesamiento, almacenamiento y transfusión de sangre, se enorgullece en anunciar una nueva asociación con la fundación...
Hemanext ONE se convierte en el primer sistema de procesamiento y almacenamiento de sangre en recibir el sello que cumple con los estándares de AABB
LEXINGTON, Massachusetts, 24 de enero de 2022, PR NEWSWIRE – Hemanext Inc. hoy anunció que Hemanext ONE®, su innovador sistema de procesamiento y almacenamiento de sangre, ha sido reconocido por la AABB (Association for the Advancement of Blood & Biotherapies:...